An unusually acrimonious dispute has arisen over patents – in particular for Covid-19 vaccines – in the US. The row between vaccine maker Moderna and its mentor, the US...
In a decision not everyone anticipated, the EU’s drugs regulator, European Medicines Agency, EMA, announced on Oct. 4 it was authorizing a booster shot of the Pfizer...
The question of what kind of particulate matter found its way into vials of Moderna’s Covid-19 vaccine deployed in Japan may have been resolved. There is as yet...
Two people died in Japan within three days after receiving their second doses of Moderna’s Covid-19 vaccine, the country's Ministry of Health, Labor and Welfare reported...
US biotech Moderna announced on Aug. 26 that it had completed its filing with the US Food and Drug Administration (FDA) for full marketing approval of its mRNA-based...
The US Food and Drug Administration (FDA) added information about myocarditis and pericarditis to its fact sheets for the mRNA-based Moderna and Pfizer/BioNTech Covid-19...
Flagship Pioneering, the venture capital fund behind US Covid vaccine manufacturer Moderna and other biotechs, said it has raised an additional $2.23 billion for its fund...
As it ramps up production on three continents, US Covid-19 vaccine manufacturer Moderna is expanding its collaborations with CDMO suppliers in Europe, the US and Asia. At...
